The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BSGM | +227.66% | -89.71% | -36.53% | -94% |
| S&P | +12.66% | +85.37% | +13.13% | +244% |
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Westport. CT.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | 0.0% |
| Gross Profit | -$1.49M | -4700.0% |
| Gross Margin | -130.77% | 544.2% |
| Market Cap | $203.16M | 3570.7% |
| Market Cap / Employee | $40.63M | 0.0% |
| Employees | 5 | 25.0% |
| Net Income | -$15.58M | -714.2% |
| EBITDA | -$4.63M | -58.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $11.05M | 1695.9% |
| Accounts Receivable | $0.00M | -100.0% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00M | 0.0% |
| Short Term Debt | $0.00M | -100.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -60.44% | 608.0% |
| Return On Invested Capital | -364.47% | 201.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$5.02M | -237.3% |
| Operating Free Cash Flow | -$5.02M | -237.3% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -61.14 | -24.67 | 66.46 | -49.04 | -94.23% |
| Price to Sales | 642.16 | 480.68 | 15217.42 | 14777.50 | 10362.77% |
| Price to Tangible Book Value | -36.46 | -14.71 | 73.99 | -1.61 | -91.07% |
| Enterprise Value to EBITDA | -22.35 | -3.03 | -9.85 | -39.18 | 2116.18% |
| Return on Equity | -8041.7% | - | |||
| Total Debt | $0.10M | $0.06M | $0.02M | $0.00M | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
